DEANNA MOORE: Open Payments
NPI 1386135515 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 20 payments from 10 companies in 2025. Trend: 2023 $2,402 · 2024 $1,905 · 2025 $415
Food & beverage: $330Education: $85
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| Incyte Corporation | 3 | $68 |
| ABBVIE INC. | 3 | $65 |
| Organon LLC | 5 | $46 |
| Amgen Inc. | 2 | $38 |
| PFIZER INC. | 2 | $36 |
| UCB, Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Botanix SB Inc | 1 | $15 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
Products named: DUPIXENT, OPZELURA, RINVOQ, OTEZLA, CIBINQO, VTAMA, Bimzelx, COSENTYX.
Industry payments across TX — which companies pay providers there.
